Quartalsergebnisse (Earnings) für Merck & Co

defenseworld.net2026-10-05 15:13:05

Merck & Co., Inc. $MRK Stock Position Decreased by Park National Corp OH

Park National Corp OH trimmed its stake in Merck and Co., Inc. (NYSE: MRK) by 6.1% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 120,805 shares of the company's stock after selling 7,788 shares during the quarter. Park National Corp OH's

defenseworld.net2026-10-05 14:24:47

Merck & Co., Inc. $MRK Shares Sold by Ferguson Wellman Capital Management Inc.

Ferguson Wellman Capital Management Inc. lessened its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 1.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 369,628 shares of the company's stock after selling 7,016 shares

defenseworld.net2026-10-05 14:24:47

Rockland Trust Co. Lowers Stake in Merck & Co., Inc. $MRK

Rockland Trust Co. lowered its position in Merck and Co., Inc. (NYSE: MRK) by 6.5% in the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 458,433 shares of the company's stock after selling 31,616 shares during the quarter. Merck and Co., Inc. comprises 2.5%

defenseworld.net2026-10-05 13:44:54

Merck & Co., Inc. $MRK Stake Lifted by Eastern Bank

Eastern Bank increased its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 2.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 195,900 shares of the company's stock after purchasing an additional 4,140 shares during

defenseworld.net2026-10-05 13:07:28

Merck & Co., Inc. $MRK Stock Sold by Argent Capital Management LLC

Argent Capital Management LLC reduced its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 5.1% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 166,757 shares of the company's stock after selling 8,922 shares during the period. Argent Capital Management LLC's holdings in

barrons.com2026-10-05 10:23:00

Vaxcyte Stock Spikes 57% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck

Vaxcyte is poised to capture significant share of a $3 billion to $6 billion market following the latest trial results, Jefferies says.

defenseworld.net2026-10-05 07:05:38

Merck & Co., Inc. $MRK Stock Position Lowered by MassMutual Private Wealth & Trust FSB

MassMutual Private Wealth and Trust FSB lessened its holdings in Merck and Co., Inc. (NYSE: MRK) by 6.9% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 140,363 shares of the company's stock after selling 10,415 shares during the period. MassMutual

seekingalpha.com2026-10-02 18:18:54

Dividend Champion, Contender, And Challenger Highlights: Week October 4

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

youtube.com2026-10-01 13:12:14

Moderna, Merck Rally On Cancer Vaccine Promise. But Is The Multi-Billion-Dollar Hype Real?

Moderna and Merck are eyeing a multi-billion-dollar market with their personalized mRNA cancer vaccine. But Wall Street analysts warn of potential valuation froth.

247wallst.com2026-10-01 12:15:25

JNJ or MRK: One Dividend Is Built to Last, One Faces a Reckoning

Both JNJ and MRK have surged in 2026, but a looming patent cliff and a balance sheet loaded with acquisition debt mean one of these pharma dividends faces a reckoning that retirement investors cannot afford to ignore.

EPS (USD)

Umsatz (USD)

Revisionen der Gewinnschätzungen